Loading…

Neuropathic Pain in Diabetes, Prediabetes and Normal Glucose Tolerance: The MONICA/KORA Augsburg Surveys S2 and S3

ABSTRACT Objective.  The prevalence of neuropathic pain in prediabetes and the associated risk factors in the general population are not known. The aim of this study was to determine the prevalence and risk factors of neuropathic pain in subjects with diabetes, impaired fasting glucose (IFG), impair...

Full description

Saved in:
Bibliographic Details
Published in:Pain medicine (Malden, Mass.) Mass.), 2009-03, Vol.10 (2), p.393-400
Main Authors: Ziegler, Dan, Rathmann, Wolfgang, Dickhaus, Thorsten, Meisinger, Christa, Mielck, Andreas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Objective.  The prevalence of neuropathic pain in prediabetes and the associated risk factors in the general population are not known. The aim of this study was to determine the prevalence and risk factors of neuropathic pain in subjects with diabetes, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or normal glucose tolerance (NGT). Design.  Survey of neuropathic painful polyneuropathy assessed by the Michigan Neuropathy Screening Instrument using its pain‐relevant questions and an examination score cutpoint >2 in a diabetic and control population. An oral glucose tolerance test was performed in the control subjects. Setting.  Population of the city of Augsburg and two surrounding counties. Patients.  Subjects with diabetes (N = 195) and controls matched for age and sex (N = 198) from the population‐based MONItoring trends and determinants in CArdiovascular/Cooperative Research in the Region of Augsburg (MONICA/KORA) Augsburg Surveys S2 and S3 aged 25–74 years. Results.  Among the controls, 46 (23.2%) had IGT (either isolated or combined with IFG), 71 (35.9%) had isolated IFG, and 81 had NGT. The prevalence (95% confidence interval) of neuropathic pain was 13.3 (8.9–18.9)% in the diabetic subjects, 8.7 (2.4–20.0)% in those with IGT, 4.2 (0.9–11.9)% in those with IFG, and 1.2 (0.03–6.7)% in those with NGT (overall P = 0.003). In the entire population (N = 393), age, weight, peripheral arterial disease (PAD), and diabetes were risk factors significantly associated with neuropathic pain, while in the diabetic group, these factors were age, weight, and PAD (all P 
ISSN:1526-2375
1526-4637
DOI:10.1111/j.1526-4637.2008.00555.x